InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Richardson Peter C, Directeur Médical. Director active across 2 companies, notably Antares Pharma, INC.. In total, 6 filings have been logged. Activity tracked since 10 June 2021. The latest transaction was filed on 14 November 2023 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
3,419 sharesOrdinary SharesSEC:0001104659-25-000369:0
75,091 shares0Ordinary SharesSEC:0001104659-23-119117:0
75,091 shares0Ordinary SharesSEC:0001104659-23-010375:0
36,199 shares@ US$5.6041.8% of flowCommon StockSEC:0000899243-22-019794:0
36,199 shares@ US$4.4229.1% of flowCommon StockSEC:0001209191-21-040338
36,199 shares@ US$4.4229.1% of flowCommon StockSEC:0001209191-21-040338:0
6 of 6 declarations
About Richardson Peter C
Peter C. Richardson is Executive Vice President and Chief Medical Officer at Antares Pharma, Inc. He is responsible for leading research and medical development, ensuring innovation and effectiveness of the company's products.
